Bisphosphonate-associated arthritis

Journal of Clinical Rheumatology

Volumn 12, Issue 3, 2006, Pages 131-133

  Diaz Borjon, Alejandro ^a   Seyler, Thorsten M ^a   Chen, Natasha L ^a   Lim, S Sam ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute phase response; Adverse effect; Arthritis; Bisphosphonates; Breast carcinoma; Proinflammatory cytokine

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; PAMIDRONIC ACID; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; ZOLEDRONIC ACID;

ACUTE PHASE RESPONSE; ADULT; ARTHRITIS; ARTHRODESIS; ARTHROPATHY; ARTICLE; BONE METASTASIS; BREAST CARCINOMA; CLINICAL FEATURE; DRUG MECHANISM; EFFUSION; FEMALE; HUMAN; HYPERCALCEMIA; IN VIVO STUDY; KNEE PAIN; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; RHEUMATOLOGY; SYMPTOM; SYNOVIAL FLUID; TREATMENT WITHDRAWAL;

ARTHRITIS; BONE DENSITY CONSERVATION AGENTS; BREAST NEOPLASMS; DIPHOSPHONATES; FATAL OUTCOME; FEMALE; HUMANS; HYPERCALCEMIA; IMIDAZOLES; INFUSIONS, INTRAVENOUS; MIDDLE AGED;

EID: 33748127944     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000221796.06383.4e     Document Type: Article

References (17)

1. Benford HL, Frith JC, Auriola S, et al. Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs. Mol Pharmacol. 1999;56:131-140.
2. Valleala H, Laitinen K, Pylkkanen L, et al. Clinical and biochemical response to single infusion of clodronate in active rheumatoid arthritis - a double blind placebo controlled study. Inflamm Res. 2001;50:598-601.
3. Ralston SH, Hacking L, Willocks L, et al. Clinical, biochemical, and radiographic effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis. Ann Rheum Dis. 1989;48:396-399.
4. Van Offel JF, Schuerwegh AJ, Bridts CH, et al. Influence of cyclic intravenous pamidronate on proinflammatory monocytic cytokine profiles and bone density in rheumatoid arthritis treated with low dose prednisolone and methotrexate. Clin Exp Rheumatol. 2001;19:13-20.
5. Bjorkengren AG, AlRowaih A, Lindstrand A, et al. Spontaneous osteonecrosis of the knee: value of MR imaging in determining prognosis. AJR Am J Roentgenol. 1990;154:331-336.
6. Ruggiero SL, Mehrotra B, Rosenberg TJ, et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004;62:527-534.
7. Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med. 2005;353:99-102; discussion 199-102.
8. Gerster JH. Acute polyarthritis related to once-weekly alendronate in a woman with osteoporosis. J Rheumatol. 2004;31:829-830.
9. Zysk SP, Durr HR, Gebhard HH, et al. Effects of ibandronate on inflammation in mouse antigen-induced arthritis. Inflamm Res. 2003;52:221-226.
10. Pietschmann P, Stohlawetz P, Brosch S, et al. The effect of alendronate on cytokine production, adhesion molecule expression, and transendothelial migration of human peripheral blood mononuclear cells. Calcif Tissue Int. 1998;63:325-330.
11. Monkkonen J, Simila J, Rogers MJ. Effects of tiludronate and ibandronate on the secretion of proinflammatory cytokines and nitric oxide from macrophages in vitro. Life Sci. 1998;62:PL95-102.
12. Sauty A, Pecherstorfer M, Zimmer-Roth I, et al. Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone. 1996;18:133-139.
13. Richards PJ, Amos N, Williams AS, et al. Pro-inflammatory effects of the aminobisphosphonate ibandronate in vitro and in vivo. Rheumatology (Oxford). 1999;38:984-991.
14. Thiebaud D, Sauty A, Burckhardt P, et al. An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int. 1997;61:386-392.
15. Dicuonzo G, Vincenzi B, Santini D, et al. Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6. J Interferon Cytokine Res. 2003;23:649-654.
16. Adami S, Bhalla AK, Dorizzi R, et al. The acute-phase response after bisphosphonate administration. Calcif Tissue Int. 1987;41:326-331.
17. Lippi G, Braga V, Adami S, et al. Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response. Clin Chim Acta. 1998;271:79-87.